Your browser doesn't support javascript.
Assessment of attitude and hesitancy toward vaccine against COVID-19 in a Pakistani population: A mix methods survey.
Khan, Z A; Allana, R; Afzal, I; Ali, A S; Mariam, O; Aslam, R; Shah, I A; Allana, A; Haider, M M; Jandani, R; Khan, Z; Siddiqui, A M; Shah, J A; Butt, U.
  • Khan ZA; Research Lead, Research and Development Department, AO Hospital, Karachi, Pakistan.
  • Allana R; Research Associate, Department of Paediatrics, Agha Khan University Hospital, Karachi, Pakistan.
  • Afzal I; Research Lead, Academic Surgical Unit, South West London Elective Orthopaedic Centre, London, UK.
  • Ali AS; Research Associate, Department of Medicine, Agha Khan University Hospital, Karachi, Pakistan.
  • Mariam O; Postgraduate Trainee in Biostatistics and Epidemiology, School of Public Health, Dow University of Health Science, Karachi, Pakistan.
  • Aslam R; Postgraduate Trainee in Biostatistics and Epidemiology, School of Public Health, Dow University of Health Science, Karachi, Pakistan.
  • Shah IA; Consultant Orthopaedic and Trauma Surgeon, Department of Trauma and Orthopaedics, Medical Director, AO Hospital, Karachi, Pakistan.
  • Allana A; MSc Candidate in Epidemiology and Biostatistics, Department of Community Health Sciences, Agha Khan University Hospital, Karachi, Pakistan.
  • Haider MM; Lecturer, Department of Community Dentistry, Bahria University Medical and Dental College, Karachi, Pakistan.
  • Jandani R; Lecturer, Dow Institute of Nursing and Midwifery, Dow University of Health Sciences, Karachi, Pakistan.
  • Khan Z; Consultant Orthopaedic Surgeon, Department of Orthopaedic Surgery, AO Hospital, Karachi, Pakistan.
  • Siddiqui AM; Consultant Orthopaedic and Spine Surgeon, Department of Spinal Surgery, A.O. Hospital, Karachi, Pakistan and Consultant Spinal Surgeon, Guys and St Thomas's NHS Trust, UK.
  • Shah JA; Consultant Orthopaedic and Trauma Surgeon, AO Hospital, Karachi, Pakistan.
  • Butt U; Sports Injury Unit, AO Hospital, Karachi, Pakistan.
Vacunas ; 23: S26-S32, 2022 May.
Article in English | MEDLINE | ID: covidwho-1677202
ABSTRACT

Objective:

The objective of this study was to assess the attitude and hesitancy toward vaccine against COVID-19 in a Pakistani Population. Materials and

methods:

A mix-method, prospective study was conducted and adults (aged ≥18 years) residing in Pakistan were invited to participate. The questionnaire was prepared, hosted in Google Forms and circulated through electronic platforms and was also available to be done in in-person. Data was compiled from 15th September to 30th November 2020.

Results:

The response rate was 80%. A total of 1003 participants were included in the final analysis. Of them, 75% completed survey questionnaire online, while remaining 25% responded in-person. The mean age of the participants was 29.62 ± 10.47 years. The majority of participants were females; 60.9% (n = 611). 57.02% (n = 572) of the participants were employed at the time of survey. Overall, 70.68% (n = 709) of the participants had previous experience of vaccines such as the flu vaccine Only 4.9% (n = 49) participants thought that they will be seriously ill from COVID-19 within six months and 39% (n = 392) participants were confident that they will get COVID-19. A total of 71.29% of the participants reported they would consider getting vaccinated once available. There was statistical association between gender and getting vaccinated (P < 0.001).

Conclusion:

This study demonstrated that majority of the participants showed positive attitude toward considering COVID-19 vaccine. However awareness with informed knowledge of efficacy, possible adverse effects and cost would be of added great value to increase the real response of Pakistani population toward COVID-19 vaccination.
RESUMEN

Objetivo:

El objetivo de este estudio fue evaluar la actitud y la renuencia hacia la vacuna frente a la COVID-19 en una población paquistaní. Materiales y

métodos:

Se realizó un estudio prospectivo de método mixto, invitándose a participar a personas adultas (edad ≥18 años) residentes en Paquistán. Se preparó el cuestionario, que se alojó en Google Forms y se hizo circular a través de plataformas electrónicas, pudiendo realizarse también de manera personal. Los datos se recopilaron desde el 15 de septiembre al 30 de noviembre de 2020.

Resultados:

La tasa de respuesta fue del 80%. El análisis final incluyó un total de 1.003 participantes, de los cuales el 75% completó el cuestionario-encuesta online, mientras que el 25% respondió en persona. La edad media de los participantes fue de 29,62 ± 10,47 años. La mayoría de los participantes eran mujeres el 60,9% (n = 611). El 57,02% (n = 572) de los participantes tenía empleo en el momento de la encuesta. En general, el 70,68% (n = 709) de los participantes tenía experiencia previa sobre vacunas tales como la vacuna frente a la gripe. Solo el 4,9% (n = 49) de los participantes pensaba que padecerían la COVID-19 de forma grave en el plazo de seis meses, y el 39% (n = 392) de los participantes estaba seguro de que se contagiaría de dicha enfermedad. El 71,29% de los participantes reportó que consideraría recibir la vacuna una vez que se dispusiera de la misma. Existió una asociación estadística entre el sexo y el ser vacunado (P< 0,001).

Conclusión:

Este estudio demostró que la mayoría de los participantes mostró una actitud positiva hacia la consideración de la vacuna frente a la COVID-19. Sin embargo, la concienciación sobre el conocimiento informado de la vacuna, los posibles efectos adversos y el coste supondrían un gran valor añadido al incremento de la respuesta real de la población paquistaní hacia la vacuna frente a la COVID-19.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Language: English Journal: Vacunas Year: 2022 Document Type: Article Affiliation country: J.vacun.2021.08.002

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Language: English Journal: Vacunas Year: 2022 Document Type: Article Affiliation country: J.vacun.2021.08.002